ThursdayDec 05, 2024 3:22 pm

QualityStocksNewsBreaks – Synergy CHC Corp. (NASDAQ: SNYR) Completes $10M IPO

Synergy (NASDAQ: SNYR), a provider of consumer health care, beauty and lifestyle products, announced the completion of its initial public offering of 1,150,000 shares of its common stock at $9.00 per share. The shares began trading on the Nasdaq Global Market under the ticker symbol SNYR on Oct. 23, 2024. In addition, Synergy granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock at the public offering price less underwriting discounts and commissions. Synergy received approximately $8.4 million in net proceeds from the offering of which it intends to use to repay a…

Continue Reading

ThursdayDec 05, 2024 1:15 pm

QualityStocksNewsBreaks – AROYA Showcasing Future of Cultivation at MJBizCon 2024

AROYA by Addium, a leader in data-driven cultivation solutions, is unveiling groundbreaking innovations at the Marijuana Business Conference (“MJBizCon”), taking place in the Las Vegas Convention Center from Dec. 4–6, 2024. As a leading innovator in cannabis cultivation, AROYA is reimagining precision substrate irrigation and positioning a bold new brand tailored to the future. “AROYA continues to push boundaries with pioneering technology that empowers growers to maximize their yield and operate more efficiently,” said AROYA VP of Marketing, Christian Hertel. “We are excited to showcase our new irrigation solutions to MJBizCon 2024 attendees and demonstrating a simpler, smarter way to…

Continue Reading

ThursdayDec 05, 2024 11:00 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for brain and central nervous system cancers, will host a Virtual Analyst & Investor Day on December 11 from 11:30 a.m. to 1 p.m. ET. The event will feature presentations by the company’s leadership team, including CEO John Climaco, Chief Medical Officer Dr. Sandra Silberman, and VP of Clinical Operations Zena Muzyczenko, alongside key opinion leaders Dr. Michael Weller, Dr. Samuel Goldlust, and Dr. Erin Dunbar. Discussions will focus on glioblastoma multiforme (“GBM”), updates on the clinical development of Berubicin, and regulatory strategies for the company’s second asset, TPI 287. A…

Continue Reading

ThursdayDec 05, 2024 9:10 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Highlights Innovations in Neurodegenerative Drug Development on Today’s Marketplace

Annovis Bio (NYSE: ANVS), a leader in developing treatments for neurodegenerative diseases, was recently featured on Today’s Marketplace in an exclusive interview with Dr. Maria Maccecchini, Founder, President, and CEO. Dr. Maccecchini detailed Annovis Bio’s groundbreaking drug development targeting toxic proteins responsible for nerve cell damage in Alzheimer’s and Parkinson’s, as well as the company’s next-phase clinical trials. Emphasizing the broader impact of these diseases on caregivers as well as patients, Dr. Maccecchini shared insights into the meaningful progress Annovis Bio is making. The Today’s Marketplace feature continues to spotlight Annovis Bio’s leadership in addressing critical healthcare challenges, reinforcing its…

Continue Reading

WednesdayDec 04, 2024 3:49 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Eyes Growing Global Demand for Its Advanced EM Solutions

SuperCom (NASDAQ: SPCB) was featured in a recent article that discussed its award of a new contract with the Israel Prison Service state agency (“IPS”) to provide full-service electric monitoring (“EM”) capabilities for all electronically monitored criminal offender programs throughout the country. SuperCom won the contract in partnership with a nationwide security services provider through a competitive process that included several rounds of negotiations, demonstrations and system evaluations supervised by the IPS. “We are deeply honored to support Israel’s public safety infrastructure during these challenging times. Our mission goes beyond business; it is about contributing to the safety and resilience…

Continue Reading

WednesdayDec 04, 2024 2:25 pm

QualityStocksNewsBreaks – The Coretec Group Inc. (CRTG) Marks ‘Transformative Moment’ in Positioning as Global Leader in Energy and Technology

The Coretec Group (OTCQB: CRTG) today announced its decisive step toward global leadership in energy innovation with the acquisition of a controlling stake in KIB Plug Energy Co., Ltd., a prominent KOSPI-listed enterprise in South Korea. The transformative acquisition, coupled with the company’s strategic restructuring of its Core Optics subsidiary, ambitious plans for a GIGA-scale battery plant and upcoming funding initiatives, solidifies Coretec’s status as a global powerhouse in energy and technology. “This acquisition marks a transformative moment in our journey,” said Dr. Kim, co-chairman of Coretec. “We are redefining the energy landscape through groundbreaking innovations and a relentless commitment…

Continue Reading

WednesdayDec 04, 2024 12:12 pm

QualityStocksNewsBreaks – SportLync’s GolfLync App Drives Skill-Focused Connection

SportLync recently unveiled a unique live feed feature for its GolfLync app, allowing users to connect, share and elevate their game. “Often dubbed ‘Tinder for Golf,’ the GolfLync app isn’t just about connecting golfers — it’s a thriving platform for players to share tips and feedback, and enhance their game alongside a passionate community,” reads a recent article. “This can be achieved via GolfLync’s live feed, where users can post videos and photos from the course and get real-time insights. Whether it’s a tricky green or a shot down an awkward fairway, the live feed connects players who share practical…

Continue Reading

WednesdayDec 04, 2024 11:15 am

QualityStocksNewsBreaks – IBN Appoints Beck Lewellen to Lead Business Development Team

IBN (InvestorBrandNetwork), a multifaceted financial news and publishing company for private and public entities, today announced the appointment of Beck Lewellen as its new director of sales and business development. With over a decade of experience in the investor relations and communications industry, Lewellen brings a proven track record of driving sales growth and building strong customer relationships. “We are thrilled to have Beck join the IBN team. He brings a wealth of insights and knowledge, as well as proven success throughout his career to our sales organization,” said Randy Clark, director of global operations for IBN. “Beck will be…

Continue Reading

WednesdayDec 04, 2024 1:10 am

QualityStocksNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Navigating Political Landscapes and Market Dynamics

Meta (NASDAQ: META) is a leading technology company known for its social media platforms, including Facebook, Instagram and WhatsApp. The company is at the forefront of digital communication and virtual reality innovation. Meta competes with other tech giants like Google, Apple and Amazon in various sectors, including advertising, hardware and software development. CEO Mark Zuckerberg’s potential involvement in shaping tech policies under a possible Trump administration could have significant implications for the industry. As highlighted by Jason Miller, discussions are ongoing about various political issues, which could impact regulatory frameworks. This involvement may influence how technology companies operate and innovate…

Continue Reading

TuesdayDec 03, 2024 3:56 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Showcases Platform ‘Designed to Unlock New Possibilities in Cancer Therapy’

Calidi Biotherapeutics (NYSE American: CLDI) is focused on discovering more effective treatments amid projections from the American Cancer Society that 2024 will be the first year ever to see two million people diagnosed with cancer. “Calidi Biotherapeutics’ RTNova (‘CLD-400’) is an innovative systemic antitumor enveloped virotherapy designed to unlock new possibilities in cancer therapy. The platform addresses challenges presented by untargetable and untreatable metastatic diseases and offers a possible potential transformative solution with wide-ranging applications,” reads a recent article. “The company shared key information about RTNova at two recent conferences: the International Oncolytic Virotherapy Conference (‘IOVC’) in Rotterdam, Netherlands, which…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered